TRK-950 is an antibody (a protein that helps your immune system find and get rid of foreign cells, in this case your tumor cells). Experiments in the laboratory suggest that it binds with a target on the tumor cell membrane and is thought to inhibit tumor growth. The investigational drug, TRK-950 has not yet been approved for use or proven to be beneficial for the treatment of cancer.
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
OPEN TO ACCRUAL